ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 39 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +1.4% | 51,849 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $70 | -41.7% | 50,849 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $120 | +3.4% | 50,849 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $116 | -99.9% | 50,849 | -0.6% | 0.01% | -25.0% |
| Q3 2022 | $141,000 | +12.8% | 51,149 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $125,000 | -38.1% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $202,000 | -10.6% | 51,149 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $226,000 | -28.5% | 51,149 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $316,000 | -22.0% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $405,000 | -26.0% | 51,149 | 0.0% | 0.02% | -30.8% |
| Q1 2021 | $547,000 | – | 51,149 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |